Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Magimairajan Issai V"'
Autor:
Craig Erker, Magimairajan Issai Vanan, Valérie Larouche, Liana Nobre, Chantel Cacciotti, Stéphanie Vairy, Shayna Zelcer, Adam Fleming, Eric Bouffet, Nada Jabado, Geneviève Legault, Samuele Renzi, Tara McKeown, Bruce Crooks, Nirav Thacker, Vijay Ramaswamy, Hallie Coltin, Lucie Lafay-Cousin, Sylvia Cheng, Juliette Hukin, Seth Andrew Climans, Mary Jane Lim-Fat, Sarah McKillop, Sarah Lapointe, Mélanie Alves, Julie Bennett, Uri Tabori, Sébastien Perreault
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 4022-4029 (2024)
Background: The treatment of BRAF V600E gliomas with BRAF inhibitors (BRAFis) and MEK inhibitors (MEKis) has been increasingly integrated into clinical practice for pediatric low-grade gliomas (PLGGs) and pediatric high-grade gliomas (HGGs). However,
Externí odkaz:
https://doaj.org/article/18a6d0e5930647838048e65c909b0585
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Meziane Brizini, Tina Drimes, Catherine Bourne, Jessica Streilein, Annie Drapeau, Jens Wrogemann, Lori Anne Archer, Marc Del Bigio, Magimairajan Issai Vanan
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
We report a case of slipped capital femoral epiphysis (SCFE), an on target skeletal toxicity of a pan-FGFR TKI inhibitor, erdafitinib. A 13-year-old boy was diagnosed to have an optic pathway/hypothalamic glioma with signs of increased intracranial p
Externí odkaz:
https://doaj.org/article/2a4b350bfc4e45eaa1ac23189336a05c
Autor:
Sandra Judd, Gabriel Revon‐Riviere, Stephanie A. Grover, Rebecca J. Deyell, Magimairajan Issai Vanan, Victor A. Lewis, Lucie Pecheux, Alexandra P. Zorzi, Catherine Goudie, Raoul Santiago, Thai Hoa Tran, Lesleigh S. Abbott, Josee Brossard, Paul Moorehead, Saima Alvi, Carol Portwine, Avram Denburg, James A. Whitlock, Sarah Cohen‐Gogo, Daniel A. Morgenstern
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Background The need for new therapies to improve survival and outcomes in pediatric oncology along with the lack of approval and accessible clinical trials has led to “out‐of‐trial” use of innovative therapies. We conducted a retrosp
Externí odkaz:
https://doaj.org/article/ed6f3e4aa5bc4ea2ad6a15650609498b
Autor:
Sapna Oberoi, Jennifer L. P. Protudjer, Adam Rapoport, Shahrad R. Rassekh, Bruce Crooks, Harold Siden, Kathleen Decker, Prasanna Ananth, Stacy Chapman, Lynda G. Balneaves, Magimairajan Issai Vanan, Lauren E. Kelly
Publikováno v:
Cancer Reports, Vol 5, Iss 9, Pp n/a-n/a (2022)
Abstract Background Children with cancer are increasingly using cannabis therapeutically. Aim The purpose of this study was to determine the perspectives and practices of pediatric oncologists and palliative care physicians regarding the use of canna
Externí odkaz:
https://doaj.org/article/24f72cd3c0c540b695721f21d7dbc1f5
Autor:
Babu V. Sajesh, Ngoc H. On, Refaat Omar, Samaa Alrushaid, Brian M. Kopec, Wei-Guang Wang, Han-Dong Sun, Ryan Lillico, Ted M. Lakowski, Teruna J. Siahaan, Neal M. Davies, Pema-Tenzin Puno, Magimairajan Issai Vanan, Donald W. Miller
Publikováno v:
Pharmaceutics, Vol 11, Iss 9, p 481 (2019)
The blood-brain barrier (BBB) poses a major obstacle by preventing potential therapeutic agents from reaching their intended brain targets at sufficient concentrations. While transient disruption of the BBB has been used to enhance chemotherapeutic e
Externí odkaz:
https://doaj.org/article/25cc141381be4297a117030ee6ead52b